|
Mechanism5-HT1A receptor agonists |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismfibrin modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism5-HT6 receptor antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Epix Industries, Inc.
0 Patents (Medical) associated with Epix Industries, Inc.
100 Deals associated with Epix Industries, Inc.
100 Translational Medicine associated with Epix Industries, Inc.